Go to navigation
Go to content
Astrazeneca Worldwide
AstraZeneca Websites
Search
Main navigation
Home
Therapy Areas
Oncology/Infection
Cardiovascular
Gastrointestinal
Neuroscience
Respiratory/Inflammation
Drug Products
All Drug Products
Diseases & Conditions
All Diseases and Conditions
Glossary
Contact Us
Disclosure Commitment
You are here
Home
Therapy Areas
Gastrointestinal
A Prospective, Non Interventional Study to Evaluate he Effects on Quality of Life, Symptoms and Productivity in Patients With Gastroesophageal Reflux Disease (GERD) After 6 Weeks Structured Treatment in a occupational Health Care Setting
Disease
acid reflux
Drug Name
non drug study (gastrointestinal)
Generic Name
No Drug
Sponsor
AstraZeneca
Drug Status
In Development
Phase
Non-Interventional Study
Start Date
Apr 16, 2009
Study Name
NIS-GSE-DUM-2009/1
Study Id
NIS-GSE-DUM-2009/1
ClinicalTrials.gov ID
NCT00884247
Recruiting Status
Closed
Protocol Status
Not Available
Report
May 3, 2010
NIS-GSE-DUM-2009_1.pdf
(174 KB)
Page tools
Print
Bookmark this page